Cardlytics, Inc. (CDLX) vs iQSTEL Inc. (IQST)

A side-by-side comparison of Cardlytics, Inc. and iQSTEL Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CDLX vs IQST

growth of $100 · dividends reinvested · last 8y
CDLX -98.8% (-42.2%/yr)IQST -99.5% (-48.5%/yr)CDLX compounded faster over this window
0200400600Start $1002020202220242026$1$0
CDLX IQST

CDLX vs IQST: by the numbers

  • •CDLX is the larger company ($15M vs $10M market cap).
  • •Both run net losses; IQST's is the smaller (-2.43% vs -55.92% net margin).
  • •IQST grew revenue faster over the past five years (46.16% vs 4.53% CAGR).

Metrics side by side

Valuation

MetricCDLXIQST
P/S ratio0.080.02
P/B ratioN/A0.77

Profitability

MetricCDLXIQST
Gross margin47.93%2.62%
Operating margin-20.21%-0.70%
Net margin-55.92%-2.43%
ROEN/A-75.12%
ROIC-46.24%-13.75%

Growth (annualized)

MetricCDLXIQST
Revenue CAGR (5Y)4.53%46.16%
Total return CAGR (5Y)-67.88%-50.91%

Frequently asked

Which has grown faster, CDLX or IQST?
Over the past five years, IQST grew revenue faster — CDLX at a 4.53% CAGR versus IQST at 46.16%.
How have CDLX and IQST total returns compared?
Over the past 5 years, CDLX delivered -67.88% and IQST delivered -50.91% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.